Shire, DOJ Reach $350M Deal In Dermagraft FCA Investigation
Biotech company Shire on Tuesday told investors that it reached a tentative $350 million settlement with the U.S. Department of Justice to settle False Claims Act violations and Medicaid-related claims over...To view the full article, register now.
Already a subscriber? Click here to view full article